Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Hypertension. 2022 Mar 9;79(5):1112–1121. doi: 10.1161/HYPERTENSIONAHA.121.18369

Table 2.

Individual drugs within each antihypertensive agent class as used in SPRINT

Antihypertensive agent class and individual drugs Frequency of use at 12-month visit within drug class

Thiazide-type diuretic
 chlorthalidone 89%
 hydrochlorothiazide 11%

RAS blocker
 lisinopril 55%
 losartan 25%
 valsartan 17%

Calcium channel blocker
 amlodipine 90%
 diltiazem or verapamil 10%

Beta-blocker
 metoprolol 57%
 atenolol 35%
 carvedilol 5%

RAS: renin-angiotensin system; ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker